Frazier Lifesciences Acquisition Corporation ( FLAC) Stock. Should you Buy or Sell? $ 9.95
0.00 (0.00 %)
Frazier Lifesciences Acquisition Corporation Analysis
Updated on 10-09-2022
| Symbol |
FLAC |
| Price |
$9.95 |
| Beta |
0.000 |
| Volume Avg. |
$17.28 thousand |
| Market Cap |
$176.62 M |
| 52 Week Range |
$9.72 - $10.4 |
Frazier Lifesciences Acquisition Corporation opened the day at $9.95 which is 0.00 % on yesterday's close.
Frazier Lifesciences Acquisition Corporation has a 52 week high of $10.4 and 52 week low of $9.72, which is a difference of $0.68.
We like to see positive, upward trending shares, preferably with momentum.
Market capitalization is $176.62 M and total net profit is $0 which means the company is trading at inf times profit to market capitalization. Theoretically, if you were to buy Frazier Lifesciences Acquisition Corporation for $176.62 M, it would take 15 years to get your money back. Frazier Lifesciences Acquisition Corporation are in the Shell Companies space which will have a sweet spot and industry standard for net profit multiples.
Price Chart
1 D | All
Financials
Frazier Lifesciences Acquisition Corporation Stock Forecast - Is Frazier Lifesciences Acquisition Corporation a Buy or Sell?
| DCF Score | | Strong Buy |
| ROE Score | | Buy |
| ROA Score | | Neutral |
| DE Score | | Sell |
| PE Score | | Strong Sell |
| PB Score | | Strong Sell |
| Overall Recommendation | | Neutral |
Growth and Value
| PE Ratio |
62.188 |
| Dividend Yiel |
0.000 |
| Net Profit Margin |
0.000 |
Valuing Frazier Lifesciences Acquisition Corporation
| Price Book Value Ratio |
-23.022 |
Price To Book Ratio |
-23.022 |
| Price To Sales Ratio |
0.000 |
Price Earnings Ratio |
49.555 |
How liquid is Frazier Lifesciences Acquisition Corporation
| Current Ratio |
0.417 |
| Quick Ratio |
0.335 |
Debt
| Debt Ratio |
0.051 |
Debt Equity Ratio |
-1.140 |
| Long Term Debt To Capitalization |
0.000 |
Total Debt To Capitalization |
0.000 |
Latest news about Frazier Lifesciences Acquisition Corporation
About Frazier Lifesciences Acquisition Corporation
CEO :
Sector : Financial Services
Industry : Shell Companies
Website : https://www.frazierlifesciencesacquisition.com
Exchange : NASDAQ Capital Market
Description :
Frazier Lifesciences Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities in the biotechnology sector. The company was incorporated in 2020 and is based in Seattle, Washington.
